Home
>
National Drug Code (NDC)
>
Dacogen
Dacogen - 62856-600-01 - (decitabine)
Drug Information of Dacogen
| Product NDC: | 62856-600 |
| Proprietary Name: | Dacogen |
| Non Proprietary Name: | decitabine |
| Active Ingredient(s): | 50 mg/20mL & nbsp; decitabine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dacogen
| Product NDC: | 62856-600 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021790 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960503 |
Package Information of Dacogen
| Package NDC: | 62856-600-01 |
| Package Description: | 1 VIAL in 1 CARTON (62856-600-01) > 20 mL in 1 VIAL |
NDC Information of Dacogen
| NDC Code | 62856-600-01 |
| Proprietary Name | Dacogen |
| Package Description | 1 VIAL in 1 CARTON (62856-600-01) > 20 mL in 1 VIAL |
| Product NDC | 62856-600 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | decitabine |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19960503 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai Inc. |
| Substance Name | DECITABINE |
| Strength Number | 50 |
| Strength Unit | mg/20mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
